Click to Enlarge
Facebook
Twitter
A new Alzheimer’s drug called donanemab could be available on the NHS by 2025, the i reports, hailing it as a “breakthrough”. Researchers have found that treatment appears to slow the pace of the disease by a third, but there are some potential side effects – including brain swelling, the paper notes. There is also coverage of the wildfires currently affecting parts of Greece.

i Front Page 18th of March 2025

Rachel Reeves faces mounting pressure to secure backing for planned disability benefit reforms, as key figures including the Work and Pensions Secretary and senior colleagues question the potential impact on vulnerable recipients while the PM offers only cautious support.

Read More »

i Front Page 17th of March 2025

Liz Kendall’s proposed changes to disability benefits, including tighter eligibility rules and revised support measures, have sparked growing resistance from backbenchers despite No 10’s concessions, amid fears these plans could disproportionately impact vulnerable individuals.

Read More »

i Front Page 14th of March 2025

Streeting’s sweeping takeover of the £192bn health service heralds a major shake-up that promises to streamline bureaucracy, cut thousands of jobs and invest in frontline care, although staff have already expressed alarm over the scale of planned workforce reductions.

Read More »

i Front Page 13th of March 2025

Treasury proposals to cut sickness and disability benefits are prompting a heated stand-off, with Labour MPs pushing back to safeguard the vulnerable and No 10 scrambling to contain backlash over the potential reforms.

Read More »